Drug intelligence / Profile preview

carbomer vaginal gel

Development stage: Unknown
Lead developer: Meiyan Space
Modality: Small Molecules
Administration: Vaginal

Overview

Carbomer vaginal gel (also known as carbomer obstetric gel, marketed under the brand name Nuoxinshun) is a topical gel formulation developed by Chengdu Inno and SPH Sinea Pharmaceutical. It is approved in China (under drug registration number H20203283) for use during vaginal delivery to shorten labor, protect the vagina and perineum, and reduce the rate of assisted vaginal delivery or cesarean section. The gel acts primarily as a physical lubricant, forming a low-friction film in the birth canal to facilitate childbirth.

Brand names: Nuoxinshun诺欣顺
Other names: Carbomer Obstetric Gel卡波姆产道凝胶

Beyond the preview

Go deeper on carbomer vaginal gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on carbomer vaginal gel.

Explore the full profile